Simplicity Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Simplicity Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.26M	Buy	2,821 +403	+17%	+$188K	0.07%	251
2025 Q4	$1.1M	Buy	2,418 +405	+20%	+$175K	0.07%	260
2025 Q3	$788K	Sell	2,013 -1,022	-34%	-$427K	0.05%	345
2025 Q2	$1.35M	Buy	3,035 +1,736	+134%	+$800K	0.06%	271
2025 Q1	$630K	Buy	1,299 +581	+81%	+$271K	0.05%	307
2024 Q4	$289K	Buy	718 +79	+12%	+$36.6K	0.06%	246
2024 Q3	$297K	Sell	639 -26,998	-98%	-$13M	0.03%	392
2024 Q2	$13M	Sell	27,637 -850	-3%	-$369K	0.29%	68
2024 Q1	$11.9M	Buy	+28,487	New	+$12M	0.28%	71

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Simplicity Wealth's VRTX Position: Q1 2026 in Review

Simplicity Wealth increased its Vertex Pharmaceuticals (VRTX) stake by 17% in Q1 2026, buying an estimated $188K and bringing the position to 2,821 shares worth $1.26M. The position accounts for 0.07% of the portfolio, ranked #251.

Simplicity Wealth first reported a position in VRTX in Q1 2024 and has held it in 9 quarters since. The position peaked at $13M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Simplicity Wealth held 2,821 shares of Vertex Pharmaceuticals worth $1.26M as of Q1 2026.
Simplicity Wealth bought 403 Vertex Pharmaceuticals shares in Q1 2026, an estimated $188K.
Vertex Pharmaceuticals made up 0.07% of Simplicity Wealth's portfolio in Q1 2026, its #251 holding.
Simplicity Wealth first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
Simplicity Wealth's Vertex Pharmaceuticals position peaked at $13M in Q2 2024.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Simplicity Wealth's 13F filing for Q1 2026, filed 30 Apr 2026.